Results 51 to 60 of about 2,070,589 (168)

Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation

, 2006
BACKGROUND: To compare 0.7% dexamethasone-cyclodextrin aqueous eye drop solution applied once daily with 0.1% dexamethasone sodium phosphate eye drops applied three times a day for the control of postoperative inflammation after cataract surgery. METHODS:
Ahola, Virpi, Loftsson, Thorsteinn, Saari, K Matti, Nelimarkka, Laura, Stefansson, Einar   +4 more
core   +1 more source

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex®) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema

Türk Oftalmoloji Dergisi, 2021
Objectives:This study aimed to retrospectively evaluate the intraocular pressure (IOP) change in vitrectomized and non-vitrectomized patients receiving 0.7 mg intravitreal dexamethasone implant to treat macular edema due to different indications ...
Murat Garlı, Sevda Aydın Kurna, Banu Açıkalın, Ayşe Çeviker   +3 more
doaj   +1 more source

The effectiveness of vitrectomy co-adjuvant intravitreal dexamethasone implant on visual outcome in patients with proliferative diabetic retinopathy: study protocol for a prospective randomized controlled trial

Trials
Background Proliferative diabetic retinopathy (PDR) often leads to tractional retinal detachment and vitreous hemorrhage, requiring vitrectomy. Poor visual outcomes are commonly caused by macular edema and proliferative vitreous retinopathy after ...
Jipeng Li, Zhaoyang Wang, Aman Chandra, Jun Xu, Lin Liu, Meng Zhao   +5 more
doaj   +1 more source

The Role of Steroids in the Management of Macular Edema from Retinal Vein Occlusion

Oftalʹmologiâ, 2019
Aim: To analyze the effectiveness of intravitreal injection of an anti-VEGF agent (ranibizumab) and an dexametazon implant for the intravitreal injection, in real clinical life. Patients and Methods.
M. V. Budzinskaya, A. V. Shelankova, A. A. Plukhova, N. M. Nuriyeva, A. S. Sorokin   +4 more
doaj   +1 more source

Time-in-Range Analysis of Responses after Intravitreal Dexamethasone Therapy in Eyes with Diabetic Macular Edema

Ophthalmology Science
Purpose: Time in range (TIR) is a novel end point that assesses the time during which an outcome remains within a predetermined range. Because the range includes normal parameters, it is indicative of clinically meaningful benefit.
Igor Kozak, MD, PhD, Diana V. Do, MD, Hongxin Lai, PhD, Miller J. Ogidigben, PhD, Francisco J. López, MD, PhD   +4 more
doaj   +1 more source

Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema

BMC Ophthalmology, 2019
Background Diabetic macular edema (DME) can be treated with different alternatives, among them Dexamethasone intravitreal implant 0.7 mg (DEX 0.7) has demonstrated that may improve both central macular thickness (CMT) and best corrected visual acuity ...
Verónica Castro-Navarro, Enrique Cervera-Taulet, Catalina Navarro-Palop, Clara Monferrer-Adsuara, Laura Hernández-Bel, Javier Montero-Hernández   +5 more
doaj   +1 more source

Efficacy of metoclopramide and dexamethasone for postoperative nausea and vomiting: a double-blind clinical trial [PDF]

Postoperative nausea and vomiting are common complications of anaesthesia. This double-blind clinical trial assessed the incidence of nausea and vomiting after cataract surgery with intravenous anaesthesia in 100 patients randomly assigned to ...
عیسی زاده فر, خاطره, اخوان اکبری, قدرت, انتظاری, مسعود, خوشباطن, منوچهر   +3 more
core   +1 more source

Successful management of pemphigus foliaceus with mycophenolate mofetil as a steroid-sparing agent in a cat with corticosteroid-associated congestive heart failure

Journal of Feline Medicine and Surgery Open Reports
Case summary A 5-year-old British Shorthair cat was diagnosed with pemphigus foliaceus (PF) and was initially treated with methylprednisolone (0.7 mg/kg q12h), which possibly resulted in congestive heart failure (CHF).
Giulia Striuli, Sophie Vandenabeele, Margot Gheeraert, Pascale Smets   +3 more
doaj   +1 more source

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe ...
T Benfield (12435408), CS Ulrik (7728317), M Smitt (13344813), A Møller (13344783), V Jha (7723943), T Strøm (13344909), O John (7805015), K Borawake (13344786), TS Meyhoff (7765484), B Venkatesh (13344906), F Kapadia (13344771), MS Khan (13912164), N Bose (13344780), AS Andreasen (15836717), AC Brøchner (15836720), C Gluud (7778951), SN Myatra (15836702), S Dixit (13344792), BKT Vijayaraghavan (14618837), GK Vesterlund (15836708), VL Jørgensen (15836714), NE Hammond (14547524), CA Wamberg (15836729), MH Bestle (14647241), LM Poulsen (14647217), MH Møller (7763999), JV Divatia (15836723), MS Shah (15836732), L Cioccari (13344765), MS Chew (15836726), SM Jakob (14647178), A Padmanaban (13344777), MW Munch (15836699), MBN Kjær (15836663), M Helleberg (13343988), S Micallef (13344822), A Granholm (13344750), RR Wahlin (15836705), KT Kristiansen (15836711), U Shukla (13344789), BS Rasmussen (14647235), P Amin (13344912), A Perner (7766429), S Saseedharan (13344759), M Cronhjort (13344552), R Chawla (13344801), T Lange (13342926), A Bassi (13344825), IS Darfelt (15836735)   +48 more
core  

Comparative evaluation of two different doses of nebulized intraperitoneal dexamethasone on postoperative pain in laparoscopic surgeries

Journal of Anaesthesiology Clinical Pharmacology
Background and Aims: Postoperative pain is a major cause of discomfort after laparoscopic surgeries and thus necessitates prevention and treatment. This study aims to evaluate and compare two different doses of intraperitoneally nebulized (aerosol size ...
Neha Shrivastava, Rashmi Taneja, Mamta Kumari, Rajesh Sood, Niharika Grover   +4 more
doaj   +1 more source